M
MYND Life Sciences Inc
CNSX:MYND
MYND Life Sciences Inc
CNSX:MYND
Price:
0.07
CAD
Market Closed
Market Cap:
CA$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MYND Life Sciences Inc
CNSX:MYND
|
CA |
Balance Sheet
Balance Sheet Decomposition
MYND Life Sciences Inc
MYND Life Sciences Inc
Balance Sheet Decomposition is not available for
MYND Life Sciences Inc
MYND Life Sciences Inc
Balance Sheet
MYND Life Sciences Inc
MYND Life Sciences Inc
Currency: CAD
| Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
2
|
0
|
0
|
|
| Cash |
0
|
2
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
2
|
0
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
3
+2 670 300%
|
1
-76%
|
1
+22%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
2
|
3
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
0
|
0
|
4
|
6
|
|
| Long-Term Debt |
0
|
2
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
3
+4 999%
|
4
+53%
|
6
+38%
|
|
| Equity | |||||
| Common Stock |
0
|
3
|
3
|
3
|
|
| Retained Earnings |
0
|
4
|
8
|
10
|
|
| Additional Paid In Capital |
0
|
1
|
1
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-27%
|
4
-5 094%
|
5
-41%
|
|
| Total Liabilities & Equity |
0
N/A
|
3
+2 670 300%
|
1
-76%
|
1
+22%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
46
|
46
|
47
|
48
|
|
Switch to:
Switch to:
See Also
Discover More
